Viejo-Bañuelos José L, Pueyo-Bastida Ana, Fueyo-Rodríguez Arturo
Service of Pneumology, Hospital General Yagüe, Avenida Cid 96, E-09005 Burgos, Spain.
Respir Med. 2006 Dec;100(12):2137-43. doi: 10.1016/j.rmed.2006.03.043. Epub 2006 Jul 10.
The objective of this 1-week cross-sectional survey was to assess the clinical features of outpatients with chronic obstructive pulmonary disease (COPD). A one-page questionnaire was used to collect demographic data, smoking status, and COPD-related variables. Ten or 20 consecutive patients were selected from Primary care or specialised setting during a week. Pulmonary function (FEV1) was measured using an electronic device (Piko-1). The study sample comprised 11,973 COPD patients (83% men) with a mean (sd) age of 67 (10.7) years. Thirty-five percent of patients were current smokers and smoked a mean of 17.4 (9.9) cigarettes daily. COPD severity according to GOLD stages was mild in 20% of patients, moderate in 38%, severe in 30%, and very severe in 12%. A higher percentage of men showed severe (33%) or very severe (14%) disease compared to women (16% and 6%, respectively) (P<0.005). Forty-two percent of patients had severe functional impairment and 35% continued smoking. Moreover, 11% of patients with very severe COPD smoked more than 20 cigarettes a day. The mean frequency of visits in the previous year was every 4.6 (4.1) months, with cough as the main reason for consultation. The most commonly used drugs were long-acting beta2-agonists (78%) and inhaled steroids (77%). Inhaled steroids were used by 84% of patients with very severe, 82% with severe disease, 73% with moderate disease, and 69% with mild disease (chi2 for trend, P<0.0001). This survey carried out in a real life setting shows that 42% of the patients who completed the questionnaire had severe COPD, 35% of them continued smoking, and 69% of patients with mild COPD used inhaled steroids.
这项为期1周的横断面调查旨在评估慢性阻塞性肺疾病(COPD)门诊患者的临床特征。使用一页式问卷收集人口统计学数据、吸烟状况和与COPD相关的变量。在一周内从初级保健或专科机构中连续选取10名或20名患者。使用电子设备(Piko-1)测量肺功能(FEV1)。研究样本包括11973例COPD患者(83%为男性),平均(标准差)年龄为67(10.7)岁。35%的患者为当前吸烟者,平均每天吸烟17.4(9.9)支。根据GOLD分期,20%的患者COPD严重程度为轻度,38%为中度,30%为重度,12%为极重度。与女性(分别为16%和6%)相比,男性中显示重度(33%)或极重度(14%)疾病的比例更高(P<0.005)。42%的患者有严重的功能障碍,35%的患者继续吸烟。此外,11%的极重度COPD患者每天吸烟超过20支。上一年的平均就诊频率为每4.6(4.1)个月一次,咳嗽是就诊的主要原因。最常用的药物是长效β2受体激动剂(78%)和吸入性糖皮质激素(77%)。极重度患者中84%、重度患者中82%、中度患者中73%、轻度患者中69%使用吸入性糖皮质激素(趋势χ2检验,P<0.0001)。在实际环境中进行的这项调查显示,完成问卷的患者中有42%患有重度COPD,其中35%继续吸烟,轻度COPD患者中有69%使用吸入性糖皮质激素。